ARCHIVES

In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference

This article is from The Cancer Letter archive.

Vol. 17 No. 33 | August 16, 1991

Download PDF Visit The Full Archive

Related Articles

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

In Brief: Proposed Drug Act Revisions Would Provide Quick Approval Of “Breakthroughs,” IND_NDA Changes

March 24, 1978

Staff Advisory Boards To Be Formed; Three BSCs Proposed

August 11, 1995

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012